Vaishali Pharma share price
You have to be logged in to add this to Watchlist.- ₹12.05(-1.07%)June 24, 2025 15:29:51 PM IST
- NSE
- BSE
- Vol : 1.41M (NSE + BSE)Last 20 day avg : 468.95 K
Vaishali Pharma is trading -1.07% lower at Rs 12.05 as compared to its last closing price. Vaishali Pharma has been trading in the price range of 12.50 & 12.00. Vaishali Pharma has given -30.36% in this year & -6.09% in the last 5 days. The company posted a net profit of -4.29 Crores in its last quarter.Listed peers of Vaishali Pharma include Aarey Drugs & Pharmaceuticals (4.96%), Bal Pharma (-1.81%), Vaishali Pharma (-1.07%).The Mutual Fund holding in Vaishali Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Vaishali Pharma was at 0.02% in 17 May 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Key Metrics
Updated on Jun 24, 2025, 01:05 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values2.45The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.69Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.19The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Vaishali Pharma News
Vaishali Pharma Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Financial insights for Vaishali Pharma are currently unavailable
Please check back later.
Vaishali Pharma Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 13.44
- R2
- 14.20
- R3
- 14.89
Pivot12.75
- S1
- 11.99
- S2
- 11.30
- S3
- 10.54
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Vaishali Pharma Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aarey Drugs & Pharmaceuticals | Bullish | 62.40 | 4.96 | 176.93 | 30.95 | 1.15 | - | 1.43 |
| Bal Pharma | Bearish | 97.21 | -1.81 | 154.77 | 21.81 | 2.05 | 1.21 | 40.58 |
| Vaishali Pharma | Bearish | 12.05 | -1.07 | 129.17 | 40.19 | 2.5 | - | 7.12 |
| Mangalam Drugs And Organics | Bearish | 79.68 | - | 127.03 | 18.78 | 0.85 | - | 7.89 |
| Take Solutions | Bearish | 8.51 | 1.92 | 125.89 | 168.75 | 6.06 | - | - |
Vaishali Pharma Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Vaishali Pharma is currently unavailable
Please check back later.
Shareholding Insights
Promoter(s) does not have a high stake in the company- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
Vaishali Pharma Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-28 | Audited Results & Others |
| 2025-02-06 | Quarterly Results & Others |
| 2025-01-28 | Others |
| 2025-01-06 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
About the company Vaishali Pharma
- IndustryBiotechnology & Drugs
- ISININE972X01022
- BSE Code
- NSE CodeVAISHALI
Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.
Vaishali Pharma Share Price FAQs
Vaishali Pharma is trading at 12.05 as on Tue Jun 24 2025 09:59:51. This is -1.07% lower as compared to its previous closing price of 12.18.
The market capitalization of Vaishali Pharma is 129.17 Cr as on Tue Jun 24 2025 09:59:51.
The 52 wk high for Vaishali Pharma is 24.91 whereas the 52 wk low is 10.30
Vaishali Pharma can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 22.54
- Dividend Yield: 0.00%
- D/E ratio: 0.19
Vaishali Pharma reported a net profit of 0.82 Cr in 2025.
Quick Links